Luxbright AB (publ), a technology company, develops, manufactures, and sells microfocus x-ray tubes and sources for industrial and non-destructive testing applications worldwide. It also provides Luxbright IX1, an integrated x-ray source product; Luxbright MF1, an integrated microfocus x-ray tubes; and custom-made x-ray tubes. Luxbright AB (publ) was incorporated in 2012 and is headquartered in Västra Frölunda, Sweden.…
ANALYS: Candles Scandinavia Q3 – rekordresultat och teknisk köpsignal
Luxbright (STO: LXB) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 11 employees.
The shares were at 5.880 SEK on 20 November 2026, down 91.0% over 52 weeks. Its 52-week range is 3.200 SEK to 68.40 SEK: the price is 91.4% below the high and 83.8% above the low.
Its market capitalisation is 14.24M SEK.
Luxbright reports return on equity of -72.4%, an operating margin of -226.2% and revenue down 35.6% year over year.
It holds more cash than debt, a net cash position of 362.00K SEK. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.
No upcoming events tracked.